oxazoles has been researched along with gw 409544 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, JL; Gampe, RT; Kliewer, SA; Lambert, MH; McKee, DD; Montana, VG; Moore, JT; Moore, LB; Oplinger, JA; Plunket, KD; Willson, TM; Xu, HE | 1 |
| Cobb, JE; Galardi, CM; Kliewer, SA; Lambert, MH; McKee, DD; Montana, VG; Moore, JT; Nolte, RT; Parks, DJ; Plunket, KD; Shearer, BG; Stanley, TB; Stimmel, JB; Willson, TM; Xu, HE | 1 |
| Kaya, T; Sheu, SH; Vajda, S; Waxman, DJ | 1 |
| Aoyama, T; Hayakawa, M; Ito, Y; Iwabuchi, S; Kozakai, S; Kurita, N; Nakagawa, T; Nakajima, T; Yamaguchi, Y | 1 |
| Chou, KC; Ma, Y; Wang, RL; Wang, SQ; Xu, WR | 1 |
| Cano, C; Decara, JM; Fresno, N; Macias-González, M; Pavón, FJ; Pérez-Fernández, R; Rivera, P; Rodríguez de Fonseca, F; Romero-Cuevas, M; Serrano, A; Suárez, J; Vida, M | 1 |
| Baccei, CS; Bravo, Y; Broadhead, A; Bundey, R; Chen, A; Clark, R; Correa, L; Jacintho, JD; Lorrain, DS; Messmer, D; Prasit, P; Stebbins, K; Stock, N | 1 |
| Al Sharif, M; Alov, P; Diukendjieva, A; Pajeva, I; Tsakovska, I; Vitcheva, V | 1 |
8 other study(ies) available for oxazoles and gw 409544
| Article | Year |
|---|---|
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.
Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Oxazoles; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tyrosine | 2001 |
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Topics: Amino Acid Motifs; Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; DNA-Binding Proteins; Humans; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Sequence Data; Nuclear Receptor Co-Repressor 2; Oxazoles; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Sequence Alignment; Structure-Activity Relationship; Transcription Factors; Tyrosine | 2002 |
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
Topics: Alkanesulfonates; Binding Sites; Cinnamates; Computational Biology; Humans; Ligands; Oxazines; Oxazoles; Phenylpropionates; PPAR gamma; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Structure, Tertiary; Rosiglitazone; Solvents; Thiazoles; Thiazolidinediones; Thiazolidines; Tyrosine | 2005 |
Molecular mechanics and molecular orbital simulations on specific interactions between peroxisome proliferator-activated receptor PPARalpha and plasticizer.
Topics: Amino Acid Sequence; Animals; Computer Simulation; Crystallography, X-Ray; Electrons; Esters; Humans; Isomerism; Ligands; Mice; Models, Molecular; Molecular Sequence Data; Oxazoles; Plasticizers; PPAR alpha; Protein Structure, Tertiary; Thermodynamics; Tyrosine | 2008 |
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.
Topics: Binding Sites; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Ligands; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Molecular Structure; Oxazoles; PPAR alpha; PPAR gamma; Protein Structure, Tertiary; Tyrosine | 2012 |
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Amides; Animals; Blood Glucose; Cholesterol; Feeding Behavior; Gene Expression Profiling; Gene Expression Regulation; Glucose Tolerance Test; Humans; Hydrogen Bonding; Insulin; Insulin Resistance; Ligands; Liver; Male; Models, Molecular; Oleic Acids; Oxazoles; PPAR alpha; Protein Binding; Rats; Solutions; Sulfonamides; Taste; Thermogenesis; Tyrosine; Weight Gain | 2012 |
Identification of the first potent, selective and bioavailable PPARα antagonist.
Topics: Animals; Butyrates; Humans; Mice; Molecular Structure; Oxazoles; Phenylurea Compounds; PPAR alpha; Propionates; Structure-Activity Relationship; Sulfonamides; Triazoles; Tyrosine | 2014 |
Molecular Modeling Approach to Study the PPARγ-Ligand Interactions.
Topics: Humans; Hypoglycemic Agents; Ligands; Molecular Docking Simulation; Oxazoles; PPAR gamma; Protein Conformation; Quantitative Structure-Activity Relationship; Rosiglitazone; Tyrosine | 2019 |